e-learning
resources
London 2016
Tuesday, 06.09.2016
Man versus machine: waves, frequency, and more in lung function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Marcel Geerts (Raalte, Netherlands), Marcel Geerts, Irene Steenbruggen
Source:
International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Session:
Man versus machine: waves, frequency, and more in lung function
Session type:
Poster Discussion
Number:
3618
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marcel Geerts (Raalte, Netherlands), Marcel Geerts, Irene Steenbruggen. Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1. Eur Respir J 2016; 48: Suppl. 60, 3618
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Verification of flow rate stability in high-flow nasal cannula devices
Related content which might interest you:
Prediction of all cause mortality in a population sample is improved by using FEV
1
quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005
Natural decline in FEV
1
and FVC: Self versus reference equations
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
Reference values for FEV1, FVC and FEV1/FVC in Norway
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Manual revision of automated lung function grading results in an increase of accepted data and a relevant change in FEV
1
and FVC
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Re-assessing the importance of FEV
1
decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015
Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
Lung function measurement in respiratory diseases: mechanisms
Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease
Year: 2006
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
FEF
25-75%
should not yet be used to define a bronchodilator response in individuals
Source: Annual Congress 2005 - Spirometry - now and in the future
Year: 2005
Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trondelag study
Source: Eur Respir J 2001; 18: 770-779
Year: 2001
Sources of variation in forced expiratory volume in one second and forced vital capacity
Source: Eur Respir J 2006; 27: 767-773
Year: 2006
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Exercise-induced loss of forced expiratory volume in 1 second in firefighters
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace
Source: Eur Respir J 2006; 27: 374-377
Year: 2006
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction?
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Reference values for peak flow and FEV1 variation in healthy schoolchildren using home spirometry
Source: Eur Respir J 2008; 32: 1262-1268
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept